Bladder Cancer Clinical Trial
The Bladder Instillation Comparison Study
Summary
To compare the efficacy of Mitomycin C vs. Gemcitabine vs. no adjuvant treatment as a single intraoperative instillation in preventing recurrence of bladder cancer.
Full Description
This study will compare standard of care treatment for patients with non-muscle invasive bladder cancer (NMIBC). Patients will be randomized to one of three arms, Mitomycin C, Gemcitabine or no additional treatment immediately following TURBT in the operating suite. All treatment, surgical procedures and follow up care will be conducted according to standard of care treatment.
Eligibility Criteria
Inclusion Criteria:
sign an informed consent for the study
be scheduled for a TURBT for suspected non-muscle invasive bladder tumor.
Exclusion Criteria:
patients unable to consent for themselves
individuals under 18 years old
pregnant women
prisoners
patients with known allergy or intolerance to the mitomycin C or Gemcitabine
any other sound medical, psychiatric and/or social reason as determined by the investigator.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Grand Rapids Michigan, 49503, United States
Grand Rapids Michigan, 49503, United States
Grand Rapids Michigan, 49503, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.